In Biggest-Ever Israeli Biotech Exit, Medtronic Buys Mazor for $1.6B

Irish-US firm vows to continue development of Israeli robotics technology that helps surgeons perform safer and more accurate surgeries.

READ ARTICLE by Times of Israel Staff. Published by The Times of Israel, September 21, 2018

A back surgeon looks at a 3D model of a patient's spinal column in preparation for surgery using the Mazor Renaissance system (Courtesy)